dimanche 15 novembre 2026
RechercherExplore
Via News Knowledge File

Tesla Inc.

organization80% conf.·synced Nov 15, 2026

Electric vehicle and clean energy company

60
sourced metrics
1613
relationships
20
stated objectives
8
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Stock Price
390.22USD
Nov 13, 2026reference only
Price 52 Week High
489.88USD
Nov 13, 2026reference only
Market Cap
1542445205688USD
Nov 13, 2026reference only
Price 52 Week Low
298.32USD
Nov 13, 2026reference only
Stock Return Ytd
-10.9%
Nov 13, 2026reference only
Shares Outstanding
3952757946.0shares
Oct 15, 2026reference only
Cost Of Revenue
22552000000.0USD
Sep 30, 2026reference only
Cash
17853000000.0USD
Sep 30, 2026reference only
Eps
0.22USD_per_share
Sep 30, 2026reference only
Stockholders Equity
89289000000.0USD
Sep 30, 2026reference only
Rd Expense
2761000000.0USD
Sep 30, 2026reference only
Total Liabilities
67628000000.0USD
Sep 30, 2026reference only
Gross Profit
5494000000.0USD
Sep 30, 2026reference only
Total Assets
157517000000.0USD
Sep 30, 2026reference only
Operating Income
718000000.0USD
Sep 30, 2026reference only
Revenue
28046000000.0USD
Sep 30, 2026reference only
Net Income
787000000.0USD
Sep 30, 2026reference only
Operating Cash Flow
3937000000.0USD
Mar 31, 2026reference only

Stated objectives

Build gigantic chip fab for AI and potentially work with Intel

source
stated

Unveil new Tesla Roadster on April 1 and begin production one year later

source
by 2027-04-01 00:00:00stated

Deliver on promises for robotaxi and Optimus humanoid robot

source
stated

Deepen collaboration on AI technology for vehicles, robotics and autonomous systems through investment in xAI

source
stated

Strategic shift from EVs to robots and autonomy-based future

source
stated

Expand robotaxi testing to Dallas, Houston, Phoenix, Miami, Orlando, Tampa, and Las Vegas

source
target: 7 metro areas stated

Production of Optimus humanoid robots

source
target: production launch stated

Begin production of Optimus humanoid robots by end of year

source
by 2026-12-31 00:00:00stated

Expand robotaxi testing to Dallas, Houston, Phoenix, Miami, Orlando, Tampa, and Las Vegas in first half of 2026

source
target: 7 cities by 2026-06-30 00:00:00stated

Expand robotaxi testing to Dallas, Houston, Phoenix, Miami, Orlando, Tampa, and Las Vegas

source
target: 7 new cities stated

Relationship graph · 1613 connections

Competes with
317
Developed by
303
Employs
210
Covered by
163
Invested in
82
Supplies to
80
founded
65
Owns
58

Where sources disagree

We surface conflicts between sources rather than hiding them.

value conflictunresolved

Both facts measure the same attribute (cash) for the same entity (Tesla Inc.) at the same point in time (2025-12-31). Although labeled with different fiscal period categories (FY 2025 vs Q4 2025), both periods end on the same date, making them equivalent time snapshots. The values differ drastically: $16.513 billion vs $44.06 USD. Since Q4 2025 is the final quarter of FY 2025, both should report identical cash balances at period-end. A 375 million-fold magnitude difference indicates a real contradiction, likely caused by a data quality issue (unit error, miscategorization, or source error in FACT B).

value conflictunresolved

Both facts report EPS (earnings per share) for Tesla Inc. for the identical fiscal period (Q1 2026) and observation date (2026-03-31), but state conflicting values: 0.13 USD/share vs. 0.41 USD. Same entity, same metric, same time period, different reported values.

Via News coverage

This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,997
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,997 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com